Conservative resection and adjuvant plaque brachytherapy for early-stage conjunctival melanoma

Clinical and Experimental Ophthalmology

Volumn 39, Issue 4, 2011, Pages 293-298

  Karim, Rushmia ^a   Conway, R Max ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Conjunctiva; Melanoma; Radiotherapy; Surgery

Indexed keywords

IODINE 125;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONJUNCTIVA MELANOMA; CONSERVATIVE TREATMENT; CORNEA ULCER; EYE BIOPSY; FEMALE; HUMAN; INTERVENTION STUDY; INTRAOCULAR PRESSURE; MALE; MELANOMA; METASTASIS; POSTOPERATIVE PERIOD; PRIMARY TUMOR; RADIATION DOSE; RECURRENT CANCER; RETROSPECTIVE STUDY; VISUAL ACUITY;

ADULT; AGED; BRACHYTHERAPY; COMBINED MODALITY THERAPY; CONJUNCTIVAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MELANOMA; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; PILOT PROJECTS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79958737184     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2010.02469.x     Document Type: Article

References (24)

1. Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumors, The 1994 Lynn B. McMahan Lecture. Arch Ophthalmol 1997; 115: 808-15.
2. Chalasani R, Giblin M, Conway RM. Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment. Clin Experiment Ophthalmol 2006; 34: 708-14.
3. Damato B, Coupland SE. Management of conjunctival melanoma. Expert Rev Anticancer Ther 2009; 9: 1227-39.
4. Skalicky SE, Holt PE, Giblin M, Taylor S, Conway RM. Australian Cancer Network Clinical Practice Guidelines for the management of ocular and periocular melanoma: an evidence-based literature analysis. Clin Experiment Ophthalmol 2008; 36: 646-58.
5. Missotten GS, Keijser S, De Keizer RJW, Wolff-Rouendaal DD. Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sci 2005; 46: 75-82.
6. Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N, Steuhl KP. Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Br J Ophthalmol 2002; 86: 163-7.
7. Shields CL. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Trans Am Ophthalmol Soc 2000; 98: 471-92.
8. Groh MJ, Holbach LM, Kuhnel B, Conway RM, Naumann GO. Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops. Ophthalmologe 2003; 100: 708-12.
9. Walsh-Conway N, Conway RM. Plaque brachytherapy for the management of ocular surface malignancies with corneoscleral invasion. Clin Experiment Ophthalmol 2009; 37: 577-83.
10. Greene FL, Page DL, Fleming ID etal. American Joint Committee on Cancer (AJCC) Staging Manual, 7th edn. New York: Springer-Verlag, 2009.
11. Shields CL, Naseripour M, Shields JA, Freire J, Cater J. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications. Am J Ophthalmol 2003; 135: 648-56.
12. Damato B, Coupland SE. An audit of conjunctival melanoma treatment in Liverpool. Eye 2008; 23: 801-9.
13. Jakobiec FA, Rini FJ, Fraunfelder FT etal. Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma: experience with 62 cases. Ophthalmology 1988; 95: 1058-70.
14. Finger PT. Plaque radiation therapy for malignant melanoma of the iris and ciliary body. Am J Ophthalmol 2001; 132: 328-35.
15. Rundle P, Singh AD, Rennie I. Proton beam therapy for iris melanoma: a review of 15 cases. Eye 2007; 21: 79-82.
16. Arnault JP, Peiffert D, Latarche C, Chassagne JF, Barbaud A, Schmutz JL. Keloids treated with postoperative Iridium 192* brachytherapy: a retrospective study. J Eur Acad Dermatol Venereol 2009; 23: 807-13.
17. Lederman M, Wybar K, Busby E. Malignant epibulbar melanoma: natural history and treatment by Radiotherapy. British Journal of Ophthalmology 1984; 68: 605-17.
18. Lommatzsch PK, Lommatzsch RE, Kirsch I, Fuhrmann P. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. British Journal of Ophthalmology 1990; 74: 615-19.
19. Zehetmayer M, Menapace R, Kulnig W. Combined local excision and brachytherapy with ruthenium-106 in the treatment of epibulbar malignancies. Ophthalmologica 1993; 207: 133-9.
20. Zografos L, Uffer S, Bercher L, Gailloud C. Combined surgery, cryocoagulation and radiotherapy for treatment of melanoma of the conjunctiva. Klin Monatsbl Augenheilkd 1994; 204: 385-90.
21. Norregaard JC, Gerner J, Jensen OA, Ulrik Prausc J. Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Graefe's Arch Clinical Experimental Ophthalmology 1996; 234: 569-72.
22. Stannard CE, Rossall G, Sealy H, Hering ER, Pereira SB, Knowles R, Hill J. Malignant melanoma of the eyelid and palpebral conjunctiva treated with iodine-125. Brachytherapy Ophthalmology 2000; 107: 5.
23. Wuestemeyer H, Sauerwein W, Meller D, Chauvel P, Schueler A, Steuhl KP, Bornfeld N, Anastassiou G. Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma. Graefe's Arch Clin Exp Ophthalmol 2006; 244: 438-46.
24. Krause L, Ritter C, Wachtlin J, Kreusel KM, Höcht S, Foerster MH, Bechrakis NE. Recurrence rate following adjuvant strontium-90 brachytherapy after excision of conjunctival melanoma. Klin Monbl Augenheilkd 2008; 225: 649-52.